Article: OA shifts to mainstream with BioMed deal.(on Springer's acquisition of BioMed Central, and on its expected impact on open access publishing)

Byline: Daniel Griffin

OA shifts to mainstream with BioMed deal

Daniel Griffin

The acquisition of open access (OA) science publisher BioMed Central by the world's second largest STM publisher Springer could mark the transformation of OA into a mainstream publishing model.

BioMed Central publisher Matthew Cockerill said: "Springer is absolutely committed to maintaining BioMed Central's policy of full open access to all research, and this acquisition is great news for open access."

Springer CEO Derk Haank said: "This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!